The analysis demonstrated increased levels of cells double positive for CD4/GL13 and CD8/GL13 in the pancreatic cancer microenvironment that reached a statistical significance in the TC versus NAT (Figure 4A,B, p-value < 0.05). Here, BRD2 is linked to familial pancreatic carcinoma.